Tuesday, April 1, 2008

Bayer Appeals Yasmin Contraceptive Patent Invalidity

Bayer Schering Pharma AG has appealed a judge's recent finding that the patent at issue in the lawsuit against Barr Laboratories Inc. over the $488 million U.S. market for the contraceptive Yasmin is invalid due to obviousness.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)